A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2004
12/29/2004	EP1490069A2 Alpha aed and beta aed regulation of nuclear transcription, gene regulation, and/or gene expression
12/29/2004	EP1490066A1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
12/29/2004	EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
12/29/2004	EP1490064A1 Substituted pyridinones as modulators of p38 map kinase
12/29/2004	EP1490063A1 Use of proton pump inhibitors for the treatment of noncardiac chest pain
12/29/2004	EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490060A1 Antidiabetic agents
12/29/2004	EP1490058A1 Peroxisome proliferator activated receptor modulators
12/29/2004	EP1490056A1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
12/29/2004	EP1490055A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
12/29/2004	EP1490054A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
12/29/2004	EP1490049A1 Citalopram for the treatment of elevated blood pressure
12/29/2004	EP1490047A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/29/2004	EP1490044A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
12/29/2004	EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators
12/29/2004	EP1490030A1 Nanoparticulate compositions of angiogenesis inhibitors
12/29/2004	EP1490029A1 Controlled release drug delivery system of pravastatin
12/29/2004	EP1489924A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
12/29/2004	EP1489915A1 Treatment and prevention of inflammatory disorders
12/29/2004	EP1373259B1 Pyridazinone aldose reductase inhibitors
12/29/2004	EP1368046B1 Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases
12/29/2004	EP1334094B1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
12/29/2004	EP1284957A4 Purification method of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine
12/29/2004	EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/29/2004	EP1257539B1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
12/29/2004	EP1255821B1 Protein c derivatives
12/29/2004	EP1244657B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/29/2004	EP1233769A4 Novel compounds
12/29/2004	EP1226136B1 Tyrosine kinase inhibitors
12/29/2004	EP1206442A4 Substituted chiral allosteric hemoglobin modifiers
12/29/2004	EP1204646B1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor
12/29/2004	EP1196180B1 Treatment of angiogenesis dependent conditions with dextrin sulphate
12/29/2004	EP1189923B1 Aromatic and heterocyclic derivatives of phytosterols and/or phytostanols for use in treating or preventing cardiovascular disease
12/29/2004	EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof
12/29/2004	EP1148059B1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
12/29/2004	EP1135123B1 Use of isatin derivatives as ion channel activating agents
12/29/2004	EP1123274B1 Substituted phenyl derivatives, their preparation and use
12/29/2004	EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists
12/29/2004	EP1117643B1 New crystal modification n of torasemide
12/29/2004	EP1096937B1 Sustained release ranolazine formulations
12/29/2004	EP1066037B1 Use of indole-2,3-dione-3-oxime derivatives as ampa antagonists
12/29/2004	EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/29/2004	EP1045691B1 Statin-carboxyalkylether combinations
12/29/2004	EP1032560B1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate
12/29/2004	EP1009400B1 Combination therapy comprising atorvastatin and an antihypertensive agent
12/29/2004	EP1003745B1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
12/29/2004	EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY
12/29/2004	EP0830130B9 Tnf-alpha converting enzyme
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	CN1558950A Somatic cell derived embryonic stem cell and its differentiated cell
12/29/2004	CN1558911A Synthetic heparin pentasaccharides
12/29/2004	CN1558907A Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/29/2004	CN1558906A Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
12/29/2004	CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004	CN1558903A Water-soluble phenylpyridazine compounds and compositions containing the same
12/29/2004	CN1558900A Pseudopolymorphic forms of carvedilol
12/29/2004	CN1558897A Antidiabetic agents
12/29/2004	CN1558894A Method for the nitration of phenolic compounds
12/29/2004	CN1558774A Angiotensin peptide-carrier conjugates and uses thereof
12/29/2004	CN1558769A Compositions comprising organic extracts of Geum Japonicum thunb var. and the use thereof
12/29/2004	CN1558767A A pharmaceutical composition made from Chinese traditional medicine for treating snuffle, headache and preparation method thereof
12/29/2004	CN1558766A A method of reducing the 'in vivo' cholesterol ester transfer protein mediated transfer of cholesteryl esters between high density lipoproteins (HDL) and low density lipoproteins (LDL)
12/29/2004	CN1558765A Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
12/29/2004	CN1558764A Substituted urea neuropeptide Y Y5 receptor antagonists
12/29/2004	CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/29/2004	CN1557835A Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same
12/29/2004	CN1557833A Eplerenone crystalline form exhibiting enhanced dissolution rate
12/29/2004	CN1557476A Multiple biological activity polypeptide nutrient
12/29/2004	CN1557474A Blood pressure reducing natural polypeptide nutrient
12/29/2004	CN1557473A Natural nutrient for preventing and treating hypertension and coronary heart disease
12/29/2004	CN1557467A Extraction and concentration combined pure Chinese medicinal preparation for treating cardiovascular diseases
12/29/2004	CN1557456A Storax and baras camphor oral disintegration tablet and its preparing process
12/29/2004	CN1557444A Preparing process of sobering up and clearing away heat healthy product series
12/29/2004	CN1557441A Medicinal bolus with functions of dilating vessels and removing blood stasis and its preparing process
12/29/2004	CN1557428A Chinese traditional medicine for eliminating arteriosclerosis plaque
12/29/2004	CN1557427A Medicinal tea with function of reducing blood pressure
12/29/2004	CN1557426A Preparation of moschus for refreshment
12/29/2004	CN1557421A Medicine for treating cerebral thrombus and its preparing process
12/29/2004	CN1557416A Medicine preparation for treating cardiovascular and cerebrovascular diseases and its preparing process
12/29/2004	CN1557407A Botanical medicine for preventing and treating arteriosclerosis and regulating blood fat and its processing method
12/29/2004	CN1557403A Medicine for treating angiocardiopathy and cerebrovascular disease and its preparing method
12/29/2004	CN1557402A Chinese herbal medicine preparation and its preparing process and application
12/29/2004	CN1557398A Mailuo Ning oral liquid and its application in pharmacy
12/29/2004	CN1557397A Preparation of Chinese medicinal powder injection for preventing and treating thrombosis obstruction disease
12/29/2004	CN1557393A Chinese traditional medicine for treating bradycardia
12/29/2004	CN1557387A Aromatic turmeric oil extracts and its preparing process and medicinal composition containing the same
12/29/2004	CN1557386A Angitis treating medicinal liquor
12/29/2004	CN1557384A Chinese medicine contained honey for treating insomnia and hypertension and its application
12/29/2004	CN1557382A Glucoside compound preparation and its preparing process
12/29/2004	CN1557374A Medicine for treating cerebrovascular disease
12/29/2004	CN1557371A Oral administered medicated wine for treating cardiovascular and cerebrovascular diseases
12/29/2004	CN1557362A Chinese medicinal preparation for treating coronary heart disease and angina pectoris and its preparing process
12/29/2004	CN1557361A Freeze dried genseng and prepared aconite root powder injecta and its preparation
12/29/2004	CN1557358A Medicine for treating apoplexy and its preparing process
12/29/2004	CN1557347A Medicine for treating cardiac and cerebral vascular diseases and its preparation
12/29/2004	CN1557337A Preparation and application of natural biologically active components with lowering down blood pressure function
12/29/2004	CN1557336A Cardiovascular and respiratory function regulating biological active prescription
12/29/2004	CN1557329A Medicine composition for treating cardiovascular and cerebrovascular disease and its prepararing method
12/29/2004	CN1557309A Amlodipine dispersion tablet and its preparation method
12/29/2004	CN1557307A Natural composite preparation for protecting and improving cerebral and heart function and its preparation method

1 ... 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 ... 1595